{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:52:09Z","timestamp":1790034729579,"version":"4.0.1"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder of reproductive-age women characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. Insulin resistance, obesity, and dyslipidemia are central features contributing to long-term cardiometabolic risk. Emerging evidence suggests that probiotics may modulate the gut\u2013metabolic axis and improve metabolic dysfunction in PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To evaluate the efficacy of probiotic supplementation on obesity parameters, lipid profile, and insulin resistance in women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      This prospective interventional study (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 90) was conducted at a tertiary care center from June 2024 to December 2025. Women aged 18\u201340 years with a body mass index (BMI) of \u226525 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      diagnosed with PCOS according to the Rotterdam 2003 criteria were included. Participants received a daily multistrain probiotic capsule for 12 weeks. Anthropometric parameters (weight, BMI, and waist and hip circumference) and biochemical indices (fasting blood glucose, fasting insulin, and lipid profile) were assessed at baseline and after 12 weeks. Statistical analysis was performed using a paired\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test, with\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Ninety women completed the study. Statistically significant reductions (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) were observed in weight (\u22122.75 kg), BMI (\u22121.16 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ), waist circumference (\u22122.10 cm), and hip circumference (\u22122.27 cm) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001 for all). Total cholesterol (\u221212.13 mg\/dL), low-density lipoprotein (\u22123.80 mg\/dL), and very-low-density lipoprotein (\u22122.27 mg\/dL) decreased significantly, while high-density lipoprotein and triglycerides showed no significant change. Fasting blood glucose, fasting insulin, and Homeostatic Model Assessment for Insulin Resistance showed statistically significant improvement (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      Probiotic supplementation was associated with statistically significant reductions (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) in obesity indices, atherogenic lipid fractions, and insulin resistance markers in women with PCOS, suggesting a potential adjunctive role in metabolic management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aam.aam_244_26","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:00:15Z","timestamp":1779166815000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["To Study the Efficacy of Probiotic Supplementation on Obesity, Lipid Profile, and Insulin Resistance in Women with Polycystic Ovary Syndrome"],"prefix":"10.4103","author":[{"given":"Rutuja Dilip","family":"Bodake","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Shri B. M. Patil Medical College, Hospital and Research Centre, BLDE (Deemed to be University), Vijayapura, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailaja R.","family":"Bidri","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Shri B. M. Patil Medical College, Hospital and Research Centre, BLDE (Deemed to be University), Vijayapura, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Chhabra","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Shri B. M. Patil Medical College, Hospital and Research Centre, BLDE (Deemed to be University), Vijayapura, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Atufiyat","family":"Amreen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Shri B. M. Patil Medical College, Hospital and Research Centre, BLDE (Deemed to be University), Vijayapura, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,20]]},"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_244_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:30:14Z","timestamp":1786725014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_244_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":0,"URL":"https:\/\/doi.org\/10.4103\/aam.aam_244_26","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"2026-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}